Back to News
Market Impact: 0.6

Raymond James raises CrowdStrike stock price target to $485 from $390

RJFCRWDTFC
Analyst EstimatesAnalyst InsightsTechnology & InnovationCybersecurity & Data PrivacyCorporate EarningsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)Company Fundamentals
Raymond James raises CrowdStrike stock price target to $485 from $390

Raymond James raised its price target on CrowdStrike (CRWD) to $485 from $390, maintaining an Outperform rating after the company's Q1 2026 results showed revenue growing 29.4% year-over-year and forward guidance exceeding expectations. Despite InvestingPro analysis suggesting overvaluation, analysts are encouraged by CrowdStrike's growth and profitability, particularly the potential conversion of free CCP programs into contractual revenue; however, Canaccord Genuity downgraded the stock to Hold, citing a balanced risk/reward profile, while Truist Securities raised its target to $500.

Analysis

Raymond James analysts have increased their price target for CrowdStrike Holdings (CRWD) to $485 from $390, maintaining an Outperform rating, subsequent to the company's first fiscal quarter 2026 results which were consistent with prior disclosures and featured forward guidance surpassing expectations; the stock, trading near its 52-week high of $491.20 after a 60% appreciation over the past year, reported Q1 2026 earnings per share (EPS) of $0.73, exceeding the $0.65 estimate, and revenue of $1.1 billion, a 20% year-over-year increase. Total annual recurring revenue (ARR) reached $4.44 billion, surpassing analyst and consensus estimates. Despite these strong figures and a newly announced $1 billion share repurchase authorization, InvestingPro analysis indicates CrowdStrike appears overvalued. Raymond James noted a short-term divergence between revenue growth (cited at 29.4% year-over-year in their analysis) and ARR, expressing anticipation for profitability this fiscal year, partly dependent on the conversion of free CCP programs into more stable contractual revenue. This cautious optimism is echoed by other analysts: Truist Securities raised its target to $500 (Buy) and Citizens JMP reiterated a Market Outperform rating with a $500 target, while Canaccord Genuity downgraded the stock to Hold, citing a more balanced risk/reward profile, despite increasing its price target to $475. Analysts are awaiting further evidence in the second half of the fiscal year to potentially reassess the stock's premium valuation, underscoring the need for continued strong performance to justify current levels.